149 related articles for article (PubMed ID: 11239945)
1. Dopamine supports sentence comprehension in Parkinson's Disease.
Grossman M; Glosser G; Kalmanson J; Morris J; Stern MB; Hurtig HI
J Neurol Sci; 2001 Mar; 184(2):123-30. PubMed ID: 11239945
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
[TBL] [Abstract][Full Text] [Related]
3. It's all in the type of the task: Dopamine modulates kinematic patterns during competitive vs. cooperative interaction in Parkinson's disease.
Straulino E; Scaravilli T; Bulgheroni M; D'Amico E; Castiello U
Neuropsychologia; 2016 Dec; 93(Pt A):106-115. PubMed ID: 27756693
[TBL] [Abstract][Full Text] [Related]
4. Effects of Parkinson's disease and dopamine on digit span measures of working memory.
Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ
Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362
[TBL] [Abstract][Full Text] [Related]
5. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
Simioni AC; Dagher A; Fellows LK
Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
[TBL] [Abstract][Full Text] [Related]
6. The speed of lexical activation is altered in Parkinson's disease.
Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
J Clin Exp Neuropsychol; 2007 Jan; 29(1):73-85. PubMed ID: 17162724
[TBL] [Abstract][Full Text] [Related]
7. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa.
Gotham AM; Brown RG; Marsden CD
Brain; 1988 Apr; 111 ( Pt 2)():299-321. PubMed ID: 3378138
[TBL] [Abstract][Full Text] [Related]
8. Working memory in Parkinson's disease patients: clinical features and response to levodopa.
Beato R; Levy R; Pillon B; Vidal C; du Montcel ST; Deweer B; Bonnet AM; Houeto JL; Dubois B; Cardoso F
Arq Neuropsiquiatr; 2008 Jun; 66(2A):147-51. PubMed ID: 18545772
[TBL] [Abstract][Full Text] [Related]
9. Levodopa effect upon functional balance of Parkinson's disease patients.
Nova IC; Perracini MR; Ferraz HB
Parkinsonism Relat Disord; 2004 Oct; 10(7):411-5. PubMed ID: 15465397
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of sentence comprehension difficulty in primary progressive aphasia.
Grossman M; Moore P
J Neurol Neurosurg Psychiatry; 2005 May; 76(5):644-9. PubMed ID: 15834020
[TBL] [Abstract][Full Text] [Related]
11. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
Parkinson Study Group
JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
[TBL] [Abstract][Full Text] [Related]
12. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
Manza P; Schwartz G; Masson M; Kann S; Volkow ND; Li CR; Leung HC
Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
[TBL] [Abstract][Full Text] [Related]
13. The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
Osman M; Ryterska A; Karimi K; Tu L; Obeso I; Speekenbrink M; Jahanshahi M
Neuropsychologia; 2014 Jan; 53():157-64. PubMed ID: 24269857
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.
Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM
Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615
[TBL] [Abstract][Full Text] [Related]
15. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
Hanna-Pladdy B; Pahwa R; Lyons KE
J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
[TBL] [Abstract][Full Text] [Related]
17. Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease.
Mollion H; Ventre-Dominey J; Dominey PF; Broussolle E
Neuropsychologia; 2003; 41(11):1442-51. PubMed ID: 12849762
[TBL] [Abstract][Full Text] [Related]
18. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic modulation of visual-spatial working memory in Parkinson's disease.
Costa A; Peppe A; Dell'Agnello G; Carlesimo GA; Murri L; Bonuccelli U; Caltagirone C
Dement Geriatr Cogn Disord; 2003; 15(2):55-66. PubMed ID: 12566593
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.
Kulisevsky J; Avila A; Barbanoj M; Antonijoan R; Berthier ML; Gironell A
Brain; 1996 Dec; 119 ( Pt 6)():2121-32. PubMed ID: 9010015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
